Skip to main content

Table 2 Mean live Amblyomma americanum counts and efficacy relative to placebo at 12 h after treatment and post-treatment re-infestations for dogs treated with a single oral dose of sarolaner or afoxolaner on Day 01

From: Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Amblyomma americanum on dogs

Treatment

 

Day of treatment or re-infestation

 

0

7

14

21

28

35

Placebo

Range

4–20

13–33

7–27

11–34

15–36

5–26

A. mean

12.4

21.5

20.1

20.9

26.9

18.4

G. mean2

11.2a

20.5a

18.9a

19.5a

25.7a

16.6a

Sarolaner

Range

0–16

9–22

9–18

10–23

8–34

12–28

A. mean

3.8

15.0

12.6

16.9

16.9

18.4

Efficacy (%)

69.7

30.2

37.3

19.2

37.2

0.0

G. mean2

1.9b

14.4a

12.4a

16.2a

15.5b

17.6a

Efficacy (%)

82.8

29.6

34.4

17.0

39.6

0.0

P-value vs. placebo

<0.0001

0.1392

0.0791

0.4291

0.0338

0.8025

Afoxolaner

Range

0–15

8–27

8–21

9–25

8–41

12–21

A. mean

6.2

17.7

13.7

16.7

21.8

17.5

Efficacy (%)

50.2

17.8

32.1

20.2

18.8

4.8

G. mean2

4.1b

16.4a

12.6a

15.4a

18.9a,b

16.8a

Efficacy (%)

63.9

20.1

33.2

21.3

26.6

0.0

P-value vs. placebo

0.0008

0.4068

0.1427

0.3790

0.2500

0.9633

P-value vs. sarolaner

0.0657

0.6850

0.9533

0.8665

0.5317

0.8806

  1. 1 n = 6 for afoxolaner, n = 8 for placebo and sarolaner groups
  2. 2Geometric means within columns with the same superscript are not significantly different (P > 0.05)